Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY)
USD 8.0
(0.0%)
USD 8.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.21 Billion | 4.74 Billion | 5.06 Billion | 6.84 Billion | 6.02 Billion | 3.13 Billion |
| Net Income | 3.76 Billion | 6.99 Billion | 6.27 Billion | 5.6 Billion | 4.83 Billion | 4.45 Billion |
| Depreciation & Amortization | 2.36 Billion | 2.22 Billion | 2.13 Billion | 2.13 Billion | 1.88 Billion | 1.16 Billion |
| Deferred income taxes | -194.79 Million | -131.93 Million | 164.97 Million | -233.87 Million | -217.69 Million | -402.77 Million |
| Stock-based compensation | 4.56 Million | 21.99 Million | 31.33 Million | 34.74 Million | 1.23 Million | - |
| Change in working capital | -4.15 Billion | -4.68 Billion | -3.39 Billion | -2.01 Billion | -2.57 Billion | -3.71 Billion |
| Other non-cash items | 13.3 Billion | 208.91 Million | 45.6 Million | 1.11 Billion | 1.87 Billion | 1.22 Billion |
| Investing Cash Flow | -3.29 Billion | -12.47 Billion | -6.01 Billion | -1.7 Billion | -4.58 Billion | -7.69 Billion |
| Investments in PPE | -2.97 Billion | -2.68 Billion | -4.11 Billion | -3 Billion | -2.75 Billion | -1.94 Billion |
| Acquisitions | -1.16 Billion | 22.46 Million | -1.03 Billion | -2.04 Billion | -693.68 Million | -5.19 Billion |
| Investment purchases | -28.42 Billion | -39.68 Billion | -3.14 Billion | -4.49 Billion | -1.04 Billion | -1.04 Billion |
| Sales/Maturities of investments | 27.98 Billion | 30.26 Billion | 3.28 Billion | 4.8 Billion | 1.27 Billion | 1.33 Billion |
| Other Investing Activities | 1.27 Billion | -394.02 Million | -997.83 Million | 3.03 Billion | -1.36 Billion | -836.41 Million |
| Financing Cash Flow | 55.38 Million | 12.13 Billion | 1.56 Billion | -1.26 Billion | -2.32 Billion | 7.52 Billion |
| Debt repayment | -6.85 Billion | -3.08 Billion | -52.21 Billion | -47.57 Billion | -1.08 Billion | -53.2 Billion |
| Dividends payments | -2.25 Billion | -1.55 Billion | -1.36 Billion | -1.25 Billion | -1.16 Billion | -2.35 Billion |
| Common Stock Repurchased | - | - | - | - | - | 60.65 Billion |
| Common Stock Issuance | - | - | - | - | - | 2.62 Billion |
| Other Financing Activities | -4.54 Billion | 12.14 Billion | 56.45 Billion | 48.73 Billion | -822.33 Million | -193.72 Million |
| Accounts receivables | -6.43 Billion | -10.08 Billion | -6.15 Billion | -4.07 Billion | -5.08 Billion | -2.18 Billion |
| Accounts payables | 4.58 Billion | 12.64 Billion | 5.79 Billion | 1.35 Billion | 2.66 Billion | 1.71 Billion |
| Inventory | -2.3 Billion | -7.11 Billion | -3.2 Billion | 932.6 Million | 63.14 Million | -2.84 Billion |
| Other working capital | -1.00 | -131.93 Million | 164.97 Million | -233.87 Million | -217.69 Million | -868.75 Million |
| Cash at beginning of period | 26.32 Billion | 20.13 Billion | 19.57 Billion | 15.71 Billion | 16.6 Billion | 13.56 Billion |
| Cash at end of period | 29.47 Billion | 24.53 Billion | 20.13 Billion | 19.57 Billion | 15.71 Billion | 16.6 Billion |
| Capital Expenditure | -2.97 Billion | -2.68 Billion | -4.11 Billion | -3 Billion | -2.75 Billion | -1.94 Billion |
| Effect of forex changes on cash | -5.58 Million | -12.44 Million | -50.32 Million | -17.62 Million | -1.6 Million | 67.44 Million |
| Net cash flow / Change in cash | 3.15 Billion | 4.39 Billion | 561.05 Million | 3.86 Billion | -889.29 Million | 3.03 Billion |
| Free Cash Flow | 3.24 Billion | 2.05 Billion | 942.55 Million | 3.83 Billion | 3.26 Billion | 1.19 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 1.39 Billion | 1.54 Billion | 3.76 Billion | -28.77 Million | 1.18 Billion |
| Depreciation & Amortization | - | 623.77 Million | 623.77 Million | 2.36 Billion | 595.12 Million | 595.12 Million |
| Deferred income taxes | - | - | - | -194.79 Million | 8.73 Billion | -9.08 Billion |
| Stock-based compensation | - | 350.2 Thousand | - | 4.56 Million | 4.56 Million | -2.52 Million |
| Change in working capital | - | -6.53 Billion | - | -4.15 Billion | -8.73 Billion | 9.08 Billion |
| Other non-cash items | - | 5.79 Billion | -6.89 Billion | 13.3 Billion | 2.63 Billion | -1.11 Billion |
| Investing Cash Flow | -1.67 Billion | -469.69 Million | 1.72 Billion | -3.29 Billion | 166.65 Million | -384.89 Million |
| Investments in PPE | -442.09 Million | -521.57 Million | -871.61 Million | -2.97 Billion | -685.99 Million | -780.88 Million |
| Acquisitions | 2.18 Million | -33.37 Million | 8.29 Million | -1.16 Billion | -240.01 Million | -5.77 Million |
| Investment purchases | -7.45 Billion | -2.28 Billion | -7.1 Billion | -28.42 Billion | -3.04 Billion | -11.05 Billion |
| Sales/Maturities of investments | 6.37 Billion | 2 Billion | 10.05 Billion | 27.98 Billion | 4.4 Billion | 11.43 Billion |
| Other Investing Activities | -152 Million | 360.02 Million | -365.84 Million | 1.27 Billion | -269.11 Million | 18.17 Million |
| Financing Cash Flow | -3.62 Billion | 593.11 Million | 3.25 Billion | 55.38 Million | -2.49 Billion | -2.33 Billion |
| Debt repayment | -1.8 Billion | -4.32 Billion | -4.02 Billion | -6.85 Billion | -1.46 Billion | -12.1 Billion |
| Dividends payments | -2.16 Billion | -392.56 Million | -559.22 Million | -2.25 Billion | -2.25 Billion | -2.73 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 346.99 Million | -386.84 Million | -770.42 Million | -4.54 Billion | 1.23 Billion | 12.5 Billion |
| Accounts receivables | - | -7.86 Billion | - | -6.43 Billion | -6.43 Billion | 10.54 Billion |
| Accounts payables | - | - | - | 4.58 Billion | - | - |
| Inventory | - | 1.33 Billion | - | -2.3 Billion | -2.3 Billion | -1.45 Billion |
| Other working capital | - | - | - | -1.00 | - | - |
| Cash at beginning of period | 33.8 Billion | 30.04 Billion | 29.47 Billion | 26.32 Billion | 29.26 Billion | 28.68 Billion |
| Cash at end of period | 30.75 Billion | 35.34 Billion | 30.04 Billion | 29.47 Billion | 29.47 Billion | 26.57 Billion |
| Capital Expenditure | -442.09 Million | -521.57 Million | -871.61 Million | -2.97 Billion | -685.99 Million | -780.88 Million |
| Effect of forex changes on cash | -14.68 Million | -15.92 Million | 7.73 Million | -5.58 Million | 55.26 Million | -59.89 Million |
| Net cash flow / Change in cash | -3.04 Billion | 5.3 Billion | 567.43 Million | 3.15 Billion | 208.97 Million | -2.11 Billion |
| Free Cash Flow | -442.09 Million | 6.04 Billion | -6.22 Billion | 3.24 Billion | 2.51 Billion | -116.84 Million |
HYMCW
G
TELZ
VC2
QHOP
ZENTEC